Serum and Glucocorticoid-Regulated Kinase Signaling in Breast Cancer

Oncogenic activating mutations in PIK3CA, the gene encoding the catalytic subunit of phosphoinositide 3-kinase (PI 3-K), are highly prevalent in breast cancer. The protein kinase Akt is considered to be the primary effector of PIK3CA, though the mechanisms by which PI 3-K mediates tumorigenic signal...

Full description

Bibliographic Details
Main Author: Gasser, Jessica Ann
Other Authors: Toker, Alex
Language:en_US
Published: Harvard University 2014
Subjects:
Online Access:http://dissertations.umi.com/gsas.harvard:11296
http://nrs.harvard.edu/urn-3:HUL.InstRepos:11745712
id ndltd-harvard.edu-oai-dash.harvard.edu-1-11745712
record_format oai_dc
spelling ndltd-harvard.edu-oai-dash.harvard.edu-1-117457122015-08-14T15:42:50ZSerum and Glucocorticoid-Regulated Kinase Signaling in Breast CancerGasser, Jessica AnnCellular biologyMolecular biologyBiologybreast cancerINPP4BPIK3CASGK3signal transductionOncogenic activating mutations in PIK3CA, the gene encoding the catalytic subunit of phosphoinositide 3-kinase (PI 3-K), are highly prevalent in breast cancer. The protein kinase Akt is considered to be the primary effector of PIK3CA, though the mechanisms by which PI 3-K mediates tumorigenic signals in an Akt-independent manner remain obscure. My studies show that the serum and glucocorticoid-regulated kinases (SGKs) can function as effectors of PI 3-kinase and transduce signals to phenotypes associated with malignancy. We show that SGK3 is amplified in breast cancer and identify the mechanism by which SGK3 is activated downstream of PIK3CA, specifically through the catalytic activity of the phosphoinositide phosphatase INPP4B. Expression of INPP4B promotes SGK3 activation and in turn inhibits Akt phosphorylation. In breast cancer cell lines with elevated levels of INPP4B, SGK3 is required for proliferation in 3D and also for invasive migration. SGK3 phenotypes are in part mediated by phosphorylation of the substrate protein N-myc downstream regulated 1 (NDRG1), an established metastasis suppressor. The phosphorylation of NDRG1 leads to recruitment by F-box and WD repeat domain-containing 7 (FBW7), the substrate recognition domain of the Skp, Cullin, F-box containing (SCF) complex. Binding of Fbw7 to NDRG1 promotes its polyubiquitination and subsequent degradation by the 26S proteasome. By contrast, our studies also show that the related SGK1 isoform is polyubiquitinated by the functional E3 ubiquitin ligase Rictor-Cullin-1 complex, leading to SGK1 degradation. Proteasomal degradation of SGK1 by Rictor-Cullin-1is the first identified mTORC2-independent function of the Rictor protein. Moreover, the deregulation of SGK1 ubiquitination highlights a mechanism of SGK1 overexpression in breast cancers.Toker, Alex2014-02-25T21:50:35Z2014-02-2520132015-02-04T08:30:42ZThesis or DissertationGasser, Jessica Ann. 2014. Serum and Glucocorticoid-Regulated Kinase Signaling in Breast Cancer. Doctoral dissertation, Harvard University.http://dissertations.umi.com/gsas.harvard:11296http://nrs.harvard.edu/urn-3:HUL.InstRepos:11745712en_USopenhttp://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAAHarvard University
collection NDLTD
language en_US
sources NDLTD
topic Cellular biology
Molecular biology
Biology
breast cancer
INPP4B
PIK3CA
SGK3
signal transduction
spellingShingle Cellular biology
Molecular biology
Biology
breast cancer
INPP4B
PIK3CA
SGK3
signal transduction
Gasser, Jessica Ann
Serum and Glucocorticoid-Regulated Kinase Signaling in Breast Cancer
description Oncogenic activating mutations in PIK3CA, the gene encoding the catalytic subunit of phosphoinositide 3-kinase (PI 3-K), are highly prevalent in breast cancer. The protein kinase Akt is considered to be the primary effector of PIK3CA, though the mechanisms by which PI 3-K mediates tumorigenic signals in an Akt-independent manner remain obscure. My studies show that the serum and glucocorticoid-regulated kinases (SGKs) can function as effectors of PI 3-kinase and transduce signals to phenotypes associated with malignancy. We show that SGK3 is amplified in breast cancer and identify the mechanism by which SGK3 is activated downstream of PIK3CA, specifically through the catalytic activity of the phosphoinositide phosphatase INPP4B. Expression of INPP4B promotes SGK3 activation and in turn inhibits Akt phosphorylation. In breast cancer cell lines with elevated levels of INPP4B, SGK3 is required for proliferation in 3D and also for invasive migration. SGK3 phenotypes are in part mediated by phosphorylation of the substrate protein N-myc downstream regulated 1 (NDRG1), an established metastasis suppressor. The phosphorylation of NDRG1 leads to recruitment by F-box and WD repeat domain-containing 7 (FBW7), the substrate recognition domain of the Skp, Cullin, F-box containing (SCF) complex. Binding of Fbw7 to NDRG1 promotes its polyubiquitination and subsequent degradation by the 26S proteasome. By contrast, our studies also show that the related SGK1 isoform is polyubiquitinated by the functional E3 ubiquitin ligase Rictor-Cullin-1 complex, leading to SGK1 degradation. Proteasomal degradation of SGK1 by Rictor-Cullin-1is the first identified mTORC2-independent function of the Rictor protein. Moreover, the deregulation of SGK1 ubiquitination highlights a mechanism of SGK1 overexpression in breast cancers.
author2 Toker, Alex
author_facet Toker, Alex
Gasser, Jessica Ann
author Gasser, Jessica Ann
author_sort Gasser, Jessica Ann
title Serum and Glucocorticoid-Regulated Kinase Signaling in Breast Cancer
title_short Serum and Glucocorticoid-Regulated Kinase Signaling in Breast Cancer
title_full Serum and Glucocorticoid-Regulated Kinase Signaling in Breast Cancer
title_fullStr Serum and Glucocorticoid-Regulated Kinase Signaling in Breast Cancer
title_full_unstemmed Serum and Glucocorticoid-Regulated Kinase Signaling in Breast Cancer
title_sort serum and glucocorticoid-regulated kinase signaling in breast cancer
publisher Harvard University
publishDate 2014
url http://dissertations.umi.com/gsas.harvard:11296
http://nrs.harvard.edu/urn-3:HUL.InstRepos:11745712
work_keys_str_mv AT gasserjessicaann serumandglucocorticoidregulatedkinasesignalinginbreastcancer
_version_ 1716816858181533696